Skip to content

Clinical trials

Recurrence trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Country / region: Belgium Clear all

158 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20053
20065
20075
20084
20098
20105
20115
20125
20135
20149
20157
201612
201712
201812
20199
20208
202110
20226
20239
20246
20258
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed86
Recruiting22
Active, not recruiting22
Terminated20
Unknown status5
Withdrawn2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene13
Novartis Pharmaceuticals11
Regeneron Pharmaceuticals6
Amgen5
AstraZeneca5
Biogen5
Algemeen Ziekenhuis Maria Middelares4
Cliniques universitaires Saint-Luc- Université Catholique de Louvain4
Janssen Research & Development, LLC4
The Lymphoma Academic Research Organisation4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence158
Multiple Myeloma23
Neoplasm Metastasis17
Lymphoma, Non-Hodgkin14
Leukemia12
Precursor Cell Lymphoblastic Leukemia-Lymphoma12
Leukemia, Myeloid, Acute11
Leukemia, Lymphocytic, Chronic, B-Cell10
Neoplasms10
Ovarian Neoplasms10

Trials

Showing 51 to 75 of 158. Each trial links to its page on Pharma Observatory.

58 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.